Canadian psychedelics companies

Phase 2 I’ve written previously about how expensive clinical trials are, and how not many companies are actually cashed enough to run the trials they plan on. Companies need…
Jamaica, farewell At first glance, I didn’t know what to make of Aion Therapeutics (AION.C). There are a few moving parts, it’s a psychedelics/cannabis hybrid deal with a focus…
Halo Collective (HALO.E) and Red Light Holland (TRIP.C) filed articles of incorporation with the Oregon Secretary of State to form a 50/50 joint venture called Red Light Oregon today,…
Canada: not a big push for rec Canada is a country typically at the forefront of forward-thinking movements in health and science.   With the recent legalization of cannabis…
Numinus Wellness’ (NUMI.V) compassionate-access trial for MDMA-assisted therapy has enjoyed some success in terms of treating patients with post-traumatic stress disorder (PTSD), according to a press release. The trial…
Xphyto Therapeutics (XPHY.C) subsidiary Xphyto Laboratories added mescaline to its list of psychedelic medicine programs today, according to a press release. Earlier this month the company brought Applied Pharmaceutical…
Mind Cure Health (MCUR.C) launched iSTRYM, a digital therapeutic tool for providing data regarding patient care, procedures and protocols, as well as other resources for mental health care workers…